sevoflurane has been researched along with Anesthesia Related Hyperthermia in 64 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
Excerpt | Relevance | Reference |
---|---|---|
" Other rebounds of sevoflurane > 5 ppm occurred after apnea, DLC and PSV." | 8.31 | Rebounds of sevoflurane concentration during simulated trigger-free pediatric and adult anesthesia. ( Dennhardt, N; Heiderich, S; Krauß, T; Rüffert, H; Sümpelmann, R; Thoben, C; Zimmermann, S; Zumsande, S, 2023) |
"We report on a patient who developed two episodes of severe muscle rigidity, increased endtidal CO2 and increased creatine phosphate kinase associated with sevoflurane anesthesia." | 7.73 | Repeat episodes of severe muscle rigidity in a child receiving sevoflurane. ( Cohen, IT; Kaplan, R, 2006) |
" Other rebounds of sevoflurane > 5 ppm occurred after apnea, DLC and PSV." | 4.31 | Rebounds of sevoflurane concentration during simulated trigger-free pediatric and adult anesthesia. ( Dennhardt, N; Heiderich, S; Krauß, T; Rüffert, H; Sümpelmann, R; Thoben, C; Zimmermann, S; Zumsande, S, 2023) |
"Herein, the authors report a two-month-old infant who underwent holmium laser epiglottis retrofitting through a bronchoscope, but developed limb muscular stiffness, tachypnea, tachycardia, and hyperthermia after sevoflurane exposure." | 4.02 | The Use of Continuous Blood Purification for the Treatment of Malignant Hyperthermia in an Infant. ( Jing, Z; Li, Y; Sheng, C; Yang, C, 2021) |
"We report on a patient who developed two episodes of severe muscle rigidity, increased endtidal CO2 and increased creatine phosphate kinase associated with sevoflurane anesthesia." | 3.73 | Repeat episodes of severe muscle rigidity in a child receiving sevoflurane. ( Cohen, IT; Kaplan, R, 2006) |
"Dantrolene was administered in 24 cases." | 3.01 | Malignant hyperthermia in maxillofacial surgery: Literature review supported by case presentation. ( Aires, CCG; Amorim, JA; Carneiro, SCAS; de Souza, RRL; Diniz, DA; Santos, FG; Vasconcellos, RJH, 2023) |
"Malignant hyperthermia is a rare pharmacogenetic syndrome characterized by a severe hypermetabolic reaction after the administration of halogenated inhalational anesthetics or depolarizing muscle relaxants such as succinylcholine, or both." | 1.56 | MALIGNANT HYPERTHERMIA IN A CHILD AFTER MAGNETIC RESONANCE IMAGING: A CASE REPORT. ( Almeida, CG; Colleti Junior, J, 2020) |
"Volatile anesthetics potentially trigger malignant hyperthermia crises in susceptible patients." | 1.56 | Residual volatile anesthetics after workstation preparation and activated charcoal filtration. ( Godsch, C; Hüppe, T; Kreuer, S; Müller-Wirtz, LM; Sessler, DI; Volk, T, 2020) |
"We report a case of malignant hyperthermia related to exposure to sevoflurane during adenoidectomy surgery in a 6-year-old female." | 1.56 | Malignant hyperthermia syndrome: A rare entity. ( Esteban-Zubero, E; García-Muro, C; Gutiérrez-Delgado, JM; Riaño-Méndez, B; Sáenz-Moreno, I; Valencia-Ramos, J, 2020) |
"We report a case of malignant hyperthermia in a 3-year-old girl with microstomia but no other features of Freeman-Sheldon syndrome." | 1.42 | Malignant hyperthermia in a 3-year-old child with microstomia. ( Dierdorf, S; Evans, TA; Flores, RL; Tholpady, SS, 2015) |
"If succinylcholine was not given, MH onset was shorter during sevoflurane anesthesia than during desflurane or isoflurane." | 1.40 | Anesthetic drugs and onset of malignant hyperthermia. ( Brandom, BW; Visoiu, M; Wieland, K; Young, MC, 2014) |
"Postoperative malignant hyperthermia can sometimes be difficult to distinguish from central hyperthermia, especially after neurosurgery." | 1.40 | [Suspected case of postoperative malignant hyperthermia treated with dantrolene one week after neurosurgery]. ( Itoh, K; Kitamura, A; Nishibe, S; Usuda, Y, 2014) |
"Sevoflurane is a known triggering agent of malignant hyperthermia (MH)." | 1.39 | Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility. ( Heiderich, S; Johannsen, S; Klingler, W; Roewer, N; Schneiderbanger, D; Schuster, F, 2013) |
"When preparing the Fabius CE for the malignant hyperthermia susceptible patient, remove the vaporiser, replace the disposable tubing, the reservoir bag and the CO2 absorber." | 1.38 | Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia. ( O'Donoghue, R; O'Kelly, P; O'Rourke, J; Shanahan, H; Synnott, A, 2012) |
"Malignant hyperthermia is a potentially lethal inherited hypermetabolic syndrome that develops in susceptible individuals following administration of depolarising neuromuscular relaxants or volatile anaesthetics." | 1.37 | In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced? ( Anetseder, M; Kranke, P; Metterlein, T; Roewer, N; Schuster, F, 2011) |
"When malignant hyperthermia is diagnosed after induction of anesthesia, we found that with charcoal filters in place, the current anesthesia machine may be used for at least 67 minutes before the inspired concentration exceeds 5 ppm." | 1.37 | Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines. ( Birgenheier, N; Orr, J; Stoker, R; Westenskow, D, 2011) |
"We report a case of fulminant-malignant hyperthermia that occurred after five uneventful sevoflurane anesthetic procedures." | 1.37 | [Case of fulminant-malignant hyperthermia occurring on sixth sevoflurane anesthesia]. ( Kohjitani, A; Manabe, Y; Saitoh, Y; Shimomatsu, K; Sugiyama, K; Toya, A, 2011) |
"To diagnose malignant hyperthermia (MH) susceptibility, muscle bundles are exposed to halothane and caffeine." | 1.37 | Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study. ( Anetseder, M; Hartung, E; Metterlein, T; Roewer, N; Schuster, F, 2011) |
"We describe a case of malignant hyperthermia encountered and treated during surgical operations concurrent with an overseas humanitarian assistance mission." | 1.35 | A case of malignant hyperthermia in a child encountered during a humanitarian assistance mission to the Philippines. ( Blaschke, G; Jones, S; Pfeiffer, J; Plurad, D, 2008) |
"We report a case of per anaesthesia malignant hyperthermia (MH) arisen in a 16-year-old young man presenting antecedents of five anaesthesia with use of halogenated agents without complication and having started a typical crisis of MH after five hours of anaesthesia with sevoflurane and with recurrence of the crisis after 14 hours in ICU." | 1.35 | [A case of malignant hyperthermia arising five hours after the beginning of anaesthesia with sevoflurane and after five uneventful surgical procedures]. ( Barbier, M; Bazin, JE; Guerin, R; Lafaye, AL; Payen, JF; Viguier-Hourcastagnou, L, 2009) |
"As sevoflurane, promotes the CICR (calcium-induced calcium release) mechanism, the trigger of this case is probably sevoflurane." | 1.34 | [Case of malignant hyperthermia in which treatment was carried out smoothly]. ( Endo, K; Furuta, S; Kaneko, T; Morota, T; Obara, S; Ohmuzo, H; Onuma, T; Watanabe, K, 2007) |
"Sevoflurane was thought to be a less potent triggering agent of MH; however, in literature review, the onset of MH after exposure to sevoflurane may be associated with calcium release from the sarcoplasmic reticulum." | 1.34 | Delayed onset of sevoflurane-induced juvenile malignant hyperthermia after second exposure. ( Chen, CY; Chen, PL; Day, YJ; Lee, PC; Su, BC, 2007) |
"Malignant hyperthermia is a rare anesthetic-related disorder." | 1.34 | Suspected malignant hyperthermia during sevoflurane anesthesia. ( Hsieh, AY; Hsu, SC; Huang, WT; Yeh, HM, 2007) |
"This is indicative of malignant hyperthermia susceptibility." | 1.31 | Contractures in skeletal muscle of malignant hyperthermia susceptible patients after in vitro exposure to sevoflurane. ( Dirksen, R; Gielen, MJ; Snoeck, MM; Tangerman, A; van Egmond, J, 2000) |
"Sevoflurane was discontinued and dantrolene was given by intravenous bolus." | 1.31 | Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy. ( Genma, R; Kitahara, A; Matsushita, A; Nakamura, H; Nakano, K; Natsume, H; Nishiyama, K; Sasaki, S; Yamamoto, Y, 2001) |
"The typical explosive form of malignant hyperthermia caused by following isoflurane anaesthesia is a well-known phenomenon." | 1.31 | [Anesthetic malignant hyperthermia and multiple organ dysfunction syndrome]. ( Brossier, T; Fontaine, P; Girard, C; Gwinner, N, 2001) |
"We experienced two cases of malignant hyperthermia (MH) triggered by sevoflurane." | 1.31 | [Two pediatric cases of malignant hyperthermia caused by sevoflurane]. ( Fukumitsu, K; Kinouchi, K; Kitamura, S; Okawa, M; Tachibana, K; Taniguchi, A, 2001) |
"The authors report on a course of malignant hyperthermia (MH) in an almost 5-years old boy." | 1.30 | [Malignant hyperthermia and sevoflurane--a case report]. ( Claussen, A; Claussen, D; Freudenberg, J; Wuttig, K, 1997) |
"We experienced a case of abortive malignant hyperthermia during funnel chest surgery." | 1.29 | [A case of abortive malignant hyperthermia during funnel chest surgery]. ( Enzan, K; Komatsu, H; Suzuki, M, 1993) |
"Variations in the onset of malignant hyperthermia were observed in five Poland China swine." | 1.26 | Variations in onset of porcine malignant hyperthermia. ( Gronert, GA; Milde, JH, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (3.13) | 18.7374 |
1990's | 11 (17.19) | 18.2507 |
2000's | 19 (29.69) | 29.6817 |
2010's | 22 (34.38) | 24.3611 |
2020's | 10 (15.63) | 2.80 |
Authors | Studies |
---|---|
Aires, CCG | 1 |
de Souza, RRL | 1 |
Amorim, JA | 1 |
Santos, FG | 1 |
Diniz, DA | 1 |
Carneiro, SCAS | 1 |
Vasconcellos, RJH | 1 |
Moon, YJ | 1 |
Park, J | 1 |
Kim, JR | 1 |
Lee, SY | 1 |
Lee, J | 1 |
Cho, YG | 1 |
Kim, DS | 1 |
Zumsande, S | 1 |
Thoben, C | 2 |
Dennhardt, N | 2 |
Krauß, T | 2 |
Sümpelmann, R | 2 |
Zimmermann, S | 2 |
Rüffert, H | 2 |
Heiderich, S | 3 |
Almeida, CG | 1 |
Colleti Junior, J | 1 |
Müller-Wirtz, LM | 1 |
Godsch, C | 1 |
Sessler, DI | 1 |
Volk, T | 1 |
Kreuer, S | 1 |
Hüppe, T | 1 |
Kaura, V | 1 |
Hopkins, PM | 2 |
Gonzalez, A | 1 |
Iles, TL | 1 |
Iaizzo, PA | 1 |
Bandschapp, O | 1 |
García-Muro, C | 1 |
Sáenz-Moreno, I | 1 |
Riaño-Méndez, B | 1 |
Gutiérrez-Delgado, JM | 1 |
Valencia-Ramos, J | 1 |
Esteban-Zubero, E | 1 |
Sheng, C | 1 |
Yang, C | 1 |
Jing, Z | 1 |
Li, Y | 1 |
Valent, A | 1 |
Pharaboz, A | 1 |
Letord, A | 1 |
Boughezala, S | 1 |
Boccara, D | 1 |
Plaud, B | 1 |
Li, W | 1 |
Zhang, L | 1 |
Liang, Y | 1 |
Tong, F | 1 |
Zhou, Y | 1 |
Johannsen, S | 2 |
Klingler, W | 1 |
Schneiderbanger, D | 1 |
Roewer, N | 4 |
Schuster, F | 4 |
Visoiu, M | 1 |
Young, MC | 1 |
Wieland, K | 1 |
Brandom, BW | 1 |
Banek, R | 1 |
Weatherwax, J | 1 |
Spence, D | 1 |
Perry, S | 1 |
Muldoon, S | 1 |
Capacchione, J | 1 |
Moegele, S | 1 |
Cottron, N | 1 |
Larcher, C | 1 |
Sommet, A | 1 |
Fesseau, R | 1 |
Alacoque, X | 1 |
Minville, V | 1 |
Fourcade, O | 1 |
Kern, D | 1 |
Martin, TW | 1 |
Block, FE | 1 |
Evans, TA | 1 |
Flores, RL | 1 |
Tholpady, SS | 1 |
Dierdorf, S | 1 |
Itoh, K | 1 |
Nishibe, S | 1 |
Usuda, Y | 1 |
Kitamura, A | 1 |
Plurad, D | 1 |
Blaschke, G | 1 |
Jones, S | 1 |
Pfeiffer, J | 1 |
Gunter, JB | 1 |
Ball, J | 1 |
Than-Win, S | 1 |
Mayhew, JF | 1 |
Mychaskiw, G | 1 |
Dhaese, HL | 1 |
Martens, PR | 1 |
Müller, NH | 1 |
Casier, IM | 1 |
Mulier, JP | 1 |
Heytens, L | 1 |
Barbier, M | 1 |
Lafaye, AL | 1 |
Guerin, R | 1 |
Viguier-Hourcastagnou, L | 1 |
Payen, JF | 1 |
Bazin, JE | 1 |
Murao, K | 1 |
Umegaki, T | 1 |
Masuzawa, M | 1 |
Inoue, S | 1 |
Nakao, S | 1 |
Shingu, K | 1 |
Metterlein, T | 2 |
Kranke, P | 1 |
Anetseder, M | 2 |
Gopalakrishnan, CV | 1 |
Suparna, B | 1 |
Arun, V | 1 |
Birgenheier, N | 1 |
Stoker, R | 1 |
Westenskow, D | 1 |
Orr, J | 1 |
Sugiyama, K | 1 |
Toya, A | 1 |
Shimomatsu, K | 1 |
Saitoh, Y | 1 |
Manabe, Y | 1 |
Kohjitani, A | 1 |
Hartung, E | 1 |
Brünner, HW | 1 |
Pohl, S | 1 |
Grond, S | 1 |
Migita, T | 1 |
Mukaida, K | 2 |
Kobayashi, M | 1 |
Hamada, H | 1 |
Kawamoto, M | 1 |
Shanahan, H | 1 |
O'Donoghue, R | 1 |
O'Kelly, P | 1 |
Synnott, A | 1 |
O'Rourke, J | 2 |
Jones, C | 1 |
Bennett, K | 1 |
Kim, TW | 1 |
Bulger, TF | 1 |
Pollock, N | 1 |
Bakan, M | 1 |
Idin, K | 1 |
Karaaslan, K | 1 |
Ozturk, E | 1 |
Gillmeister, I | 1 |
Schummer, C | 1 |
Hommann, M | 1 |
Schummer, W | 1 |
Jonassen, AA | 1 |
Petersen, AJ | 1 |
Mohr, S | 1 |
Andersson, C | 1 |
Skattum, J | 1 |
Kvernebo, K | 1 |
Paulsen, OG | 1 |
Stokland, O | 1 |
Kirkebøen, KA | 1 |
Duke, AM | 1 |
Halsall, PJ | 1 |
Steele, DS | 1 |
Prinzhausen, H | 1 |
Crawford, MW | 1 |
Petroz, GC | 1 |
Cohen, IT | 1 |
Kaplan, R | 1 |
Bonciu, M | 1 |
de la Chapelle, A | 1 |
Delpech, H | 1 |
Depret, T | 1 |
Krivosic-Horber, R | 2 |
Aimé, MR | 1 |
Morota, T | 1 |
Endo, K | 1 |
Furuta, S | 1 |
Obara, S | 1 |
Ohmuzo, H | 1 |
Kaneko, T | 1 |
Onuma, T | 1 |
Watanabe, K | 1 |
Kohase, H | 1 |
Wakita, R | 1 |
Doi, S | 1 |
Umino, M | 1 |
Chen, PL | 1 |
Day, YJ | 1 |
Su, BC | 1 |
Lee, PC | 1 |
Chen, CY | 1 |
Hsu, SC | 1 |
Huang, WT | 1 |
Yeh, HM | 1 |
Hsieh, AY | 1 |
Gronert, GA | 1 |
Milde, JH | 1 |
Shulman, M | 1 |
Braverman, B | 1 |
Ivankovich, AD | 1 |
Gronert, G | 1 |
Ducart, A | 1 |
Adnet, P | 1 |
Renaud, B | 1 |
Riou, B | 1 |
Komatsu, H | 1 |
Enzan, K | 1 |
Suzuki, M | 1 |
Kanaya, N | 1 |
Nakayama, M | 1 |
Nakae, Y | 1 |
Kobayashi, I | 1 |
Tsuchida, H | 1 |
Namiki, A | 1 |
Maeda, H | 1 |
Iranami, H | 1 |
Hatano, Y | 1 |
Claussen, D | 1 |
Wuttig, K | 1 |
Freudenberg, J | 1 |
Claussen, A | 1 |
Michalek-Sauberer, A | 1 |
Gilly, H | 1 |
Scholz, J | 1 |
Goresky, GV | 1 |
Cox, RG | 1 |
Snoeck, MM | 1 |
Gielen, MJ | 1 |
Tangerman, A | 1 |
van Egmond, J | 1 |
Dirksen, R | 1 |
Terry, D | 1 |
Nishiyama, K | 1 |
Kitahara, A | 1 |
Natsume, H | 1 |
Matsushita, A | 1 |
Nakano, K | 1 |
Sasaki, S | 1 |
Genma, R | 1 |
Yamamoto, Y | 1 |
Nakamura, H | 1 |
Brossier, T | 1 |
Gwinner, N | 1 |
Fontaine, P | 1 |
Girard, C | 1 |
Kinouchi, K | 1 |
Okawa, M | 1 |
Fukumitsu, K | 1 |
Tachibana, K | 1 |
Kitamura, S | 1 |
Taniguchi, A | 1 |
Ochiai, R | 1 |
Toyoda, Y | 1 |
Nishio, I | 1 |
Takeda, J | 1 |
Sekiguchi, H | 1 |
Fukushima, K | 1 |
Kohda, E | 1 |
Otsuka, H | 2 |
Kemmotsu, O | 2 |
Komura, Y | 1 |
Mayumi, T | 1 |
Yamamura, T | 1 |
3 reviews available for sevoflurane and Anesthesia Related Hyperthermia
Article | Year |
---|---|
Malignant hyperthermia in maxillofacial surgery: Literature review supported by case presentation.
Topics: Adolescent; Adult; Child; Dantrolene; Humans; Hyperthermia, Induced; Male; Malignant Hyperthermia; M | 2023 |
Escobar syndrome: is this child prone to malignant hyperthermia?
Topics: Abnormalities, Multiple; Anesthetics, Inhalation; Halothane; Humans; Infant; Male; Malignant Hyperth | 2009 |
[Sevoflurane in pediatric anesthesia. Malignant hyperthermia].
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Child; Halothane; Humans; Malignant Hyperthermia; M | 1998 |
61 other studies available for sevoflurane and Anesthesia Related Hyperthermia
Article | Year |
---|---|
Gene Panel Sequencing Identifies a Novel
Topics: Adolescent; Caffeine; Calcium; Dantrolene; Humans; Isoflurane; Male; Malignant Hyperthermia; Ryanodi | 2022 |
Rebounds of sevoflurane concentration during simulated trigger-free pediatric and adult anesthesia.
Topics: Adult; Anesthesia; Anesthetics, Inhalation; Apnea; Child; Gases; Humans; Malignant Hyperthermia; Met | 2023 |
Preparation of anaesthesia workstation for trigger-free anaesthesia: An observational laboratory study.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Charcoal; Desflurane; Equipment Contamination; Huma | 2019 |
MALIGNANT HYPERTHERMIA IN A CHILD AFTER MAGNETIC RESONANCE IMAGING: A CASE REPORT.
Topics: Acyclovir; Anesthetics, Inhalation; Anesthetics, Intravenous; Antiviral Agents; Child, Preschool; Da | 2020 |
Residual volatile anesthetics after workstation preparation and activated charcoal filtration.
Topics: Anesthesiology; Anesthetics, Inhalation; Charcoal; Desflurane; Equipment Contamination; Filtration; | 2020 |
Sevoflurane may not be a complete sigh of relief in COVID-19.
Topics: Anesthetics, Inhalation; Coronavirus Infections; COVID-19; Critical Care; Genetic Predisposition to | 2020 |
Impact of statin intake on malignant hyperthermia: an in vitro and in vivo swine study.
Topics: Animals; Contracture; Disease Susceptibility; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Malign | 2020 |
Malignant hyperthermia syndrome: A rare entity.
Topics: Adenoidectomy; Anesthetics, Inhalation; Child; Dantrolene; Female; Humans; Malignant Hyperthermia; S | 2020 |
The Use of Continuous Blood Purification for the Treatment of Malignant Hyperthermia in an Infant.
Topics: Adult; Anesthesia, General; Child; Dantrolene; Humans; Hyperthermia; Infant; Male; Malignant Hyperth | 2021 |
Perioperative Management of an Adult Patient With Myoclonic Epilepsy With Ragged Red Fibers Syndrome: A Case Report.
Topics: Adult; Anesthesia, General; Humans; Male; Malignant Hyperthermia; MERRF Syndrome; Middle Aged; Mitoc | 2021 |
Sudden death due to malignant hyperthermia with a mutation of RYR1: autopsy, morphology and genetic analysis.
Topics: Amino Acid Substitution; Anesthetics, Inhalation; Death, Sudden; Genetic Testing; Humans; Male; Mali | 2017 |
Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
Topics: Anesthetics, Inhalation; Biopsy; Disease Susceptibility; Dose-Response Relationship, Drug; Genetic P | 2013 |
Anesthetic drugs and onset of malignant hyperthermia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics; Anesthetics, Inhalation; Child; Child, Pres | 2014 |
Delayed onset of suspected malignant hyperthermia during sevoflurane anesthesia in an Afghan trauma patient: a case report.
Topics: Afghan Campaign 2001-; Anesthetics, Inhalation; Emergency Medical Services; Humans; Male; Malignant | 2013 |
Malignant hyperthermia in the intensive care setting.
Topics: Anesthetics, Inhalation; Critical Care; Humans; Male; Malignant Hyperthermia; Methyl Ethers; Middle | 2014 |
The sevoflurane washout profile of seven recent anesthesia workstations for malignant hyperthermia-susceptible adults and infants: a bench test study.
Topics: Adult; Anesthesia, Inhalation; Anesthetics, Inhalation; Humans; Infant; Malignant Hyperthermia; Meth | 2014 |
How will we ever know if our machine is adequately flushed?
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Humans; Malignant Hyperthermia; Methyl Ethers; Sevo | 2014 |
Malignant hyperthermia in a 3-year-old child with microstomia.
Topics: Anesthetics, Inhalation; Child, Preschool; Craniofacial Dysostosis; Female; Humans; Malignant Hypert | 2015 |
[Suspected case of postoperative malignant hyperthermia treated with dantrolene one week after neurosurgery].
Topics: Administration, Oral; Adolescent; Anesthesia, General; Cerebral Hemorrhage; Dantrolene; Humans; Infu | 2014 |
A case of malignant hyperthermia in a child encountered during a humanitarian assistance mission to the Philippines.
Topics: Altruism; Anesthetics, Inhalation; Cleft Lip; Cleft Palate; Dantrolene; Female; Humans; Infant; Mali | 2008 |
Preparation of the Dräger Fabius anesthesia machine for the malignant-hyperthermia susceptible patient.
Topics: Anesthesiology; Anesthetics, Inhalation; Disease Susceptibility; Equipment Contamination; Humans; Ma | 2008 |
The use of emergency medical cooling system pads in the treatment of malignant hyperthermia.
Topics: Anesthesiology; Anesthetics, Inhalation; Atracurium; Humans; Hypothermia, Induced; Male; Malignant H | 2010 |
[A case of malignant hyperthermia arising five hours after the beginning of anaesthesia with sevoflurane and after five uneventful surgical procedures].
Topics: Adolescent; Anesthesia; Anesthetics, Inhalation; Humans; Male; Malignant Hyperthermia; Methyl Ethers | 2009 |
[Propofol triggers a marked body temperature increase in a patient with fulminant malignant hyperthermia (MH) without inducing other symptoms of MH].
Topics: Anesthesia, Intravenous; Anesthetics, Combined; Body Temperature; Colectomy; Female; Fentanyl; Human | 2010 |
In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
Topics: Anesthetics, Inhalation; Biopsy; Case-Control Studies; Desflurane; Dose-Response Relationship, Drug; | 2011 |
A rare case of malignant hyperthermia in the Indian subcontinent.
Topics: Anesthetics, Inhalation; Child; Humans; India; Male; Malignant Hyperthermia; Methyl Ethers; Sevoflur | 2010 |
Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Charcoal; Desflurane; Equipment Design; Fever; Filt | 2011 |
[Case of fulminant-malignant hyperthermia occurring on sixth sevoflurane anesthesia].
Topics: Anesthesia, General; Child; Dantrolene; Female; Humans; Malignant Hyperthermia; Methyl Ethers; Oral | 2011 |
Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study.
Topics: Anesthetics, Inhalation; Caffeine; Central Nervous System Stimulants; Disease Susceptibility; Dose-R | 2011 |
Washout of sevoflurane from the GE Avance and Amingo Carestation anesthetic machines.
Topics: Anesthesiology; Anesthetics, Inhalation; Humans; Malignant Hyperthermia; Methyl Ethers; Sevoflurane | 2011 |
The severity of sevoflurane-induced malignant hyperthermia.
Topics: Adolescent; Adult; Anesthesia, Inhalation; Anesthetics, Inhalation; Body Temperature; Child, Prescho | 2012 |
Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Decontamination; Disease Susceptibility; Disposable | 2012 |
Preparation of Datex-Ohmeda Aestiva and Aisys anaesthetic machines for use in malignant hyperthermia susceptible patients.
Topics: Anesthesia, General; Anesthesiology; Anesthetics, Inhalation; Desflurane; Humans; Isoflurane; Malign | 2012 |
Anaesthesia and orphan disease: anaesthetic management of a child with Pena-Shokeir syndrome.
Topics: Alopecia; Anesthesia; Anesthetics; Child; Cleft Palate; Craniofacial Abnormalities; Epilepsy; Female | 2012 |
[Delayed onset of malignant hyperthermia crisis during a living donor liver transplantation caused by sevoflurane].
Topics: Adult; Anesthesia, Inhalation; Anesthetics, Inhalation; Blood Gas Analysis; Caffeine; Central Nervou | 2004 |
Sevoflurane-induced malignant hyperthermia during cardiopulmonary bypass and moderate hypothermia.
Topics: Anesthetics, Inhalation; Angina Pectoris; Blood Gas Analysis; Cardiac Surgical Procedures; Cardiopul | 2004 |
Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia.
Topics: Anesthetics, Inhalation; Calcium; Cytosol; Halothane; Humans; Magnesium; Malignant Hyperthermia; Met | 2006 |
Preparation of the Dräger Primus anesthetic machine for malignant hyperthermia-susceptible patients.
Topics: Anesthesiology; Anesthetics, Inhalation; Disease Susceptibility; Equipment Contamination; Humans; Is | 2006 |
Repeat episodes of severe muscle rigidity in a child receiving sevoflurane.
Topics: Abnormalities, Multiple; Anesthetics, Inhalation; Arrhythmias, Cardiac; Carbon Dioxide; Creatine Kin | 2006 |
Minor increase of endtidal CO2 during sevoflurane-induced malignant hyperthermia.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Biopsy; Body Temperature; Carbon Dioxide; Child; | 2007 |
[Case of malignant hyperthermia in which treatment was carried out smoothly].
Topics: Adolescent; Anesthesia, General; Anesthetics, Inhalation; Dantrolene; Female; Humans; Intraoperative | 2007 |
General anesthesia for dental treatment in a Williams syndrome patient with severe aortic and pulmonary valve stenosis: suspected episode of postoperatively malignant hyperthermia.
Topics: Anesthesia, Dental; Anesthesia, General; Anesthesia, Inhalation; Aortic Stenosis, Supravalvular; Chi | 2007 |
Delayed onset of sevoflurane-induced juvenile malignant hyperthermia after second exposure.
Topics: Anesthetics, Inhalation; Child, Preschool; Humans; Male; Malignant Hyperthermia; Methyl Ethers; Sevo | 2007 |
Suspected malignant hyperthermia during sevoflurane anesthesia.
Topics: Anesthetics, Inhalation; Child, Preschool; Humans; Male; Malignant Hyperthermia; Methyl Ethers; Muta | 2007 |
Variations in onset of porcine malignant hyperthermia.
Topics: Anesthetics; Animals; Dose-Response Relationship, Drug; Ethers; Halothane; Hydrocarbons, Fluorinated | 1981 |
Sevoflurane triggers malignant hyperthermia in swine.
Topics: Animals; Ethers; Hydrocarbons, Fluorinated; Malignant Hyperthermia; Methyl Ethers; Sevoflurane; Swin | 1981 |
Malignant hyperthermia during sevoflurane administration.
Topics: Adult; Anesthetics; Caffeine; Disease Susceptibility; Ethers; Female; Halothane; Humans; Malignant H | 1995 |
[A case of abortive malignant hyperthermia during funnel chest surgery].
Topics: Anesthesia, General; Child, Preschool; Ethers; Funnel Chest; Humans; Intraoperative Complications; M | 1993 |
Hyperthermia during sevoflurane anaesthesia in arthrogryposis multiplex congenita with central nervous system dysfunction.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Arthrogryposis; Central Nervous System Diseases; Ch | 1996 |
Delayed recovery from muscle weakness due to malignant hyperthermia during sevoflurane anesthesia.
Topics: Adult; Ethers; Humans; Male; Malignant Hyperthermia; Methyl Ethers; Muscle Weakness; Sevoflurane; Ti | 1997 |
[Malignant hyperthermia and sevoflurane--a case report].
Topics: Anesthetics, Inhalation; Carbon Dioxide; Child, Preschool; Ethers; Hernia, Umbilical; Humans; Male; | 1997 |
An episode of malignant hyperthermia followed by a persisting muscle weakness.
Topics: Anesthetics, Inhalation; Humans; Male; Malignant Hyperthermia; Methyl Ethers; Muscle Weakness; Proba | 1998 |
Inhalation anesthetics and Duchenne's muscular dystrophy.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Contraindications; Disease Susceptibility; Haloth | 1999 |
Contractures in skeletal muscle of malignant hyperthermia susceptible patients after in vitro exposure to sevoflurane.
Topics: Anesthetics, Inhalation; Caffeine; Humans; In Vitro Techniques; Malignant Hyperthermia; Methyl Ether | 2000 |
Halothane, dental anaesthesia and children.
Topics: Anesthesia, Dental; Anesthetics, Inhalation; Arrhythmias, Cardiac; Child; Halothane; Humans; Maligna | 2000 |
Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy.
Topics: Acidosis, Respiratory; Adult; Anesthetics; Antithyroid Agents; Carbon Dioxide; Creatine Kinase; Dant | 2001 |
[Anesthetic malignant hyperthermia and multiple organ dysfunction syndrome].
Topics: Adult; Anesthesia, Inhalation; Anesthetics, Inhalation; Cholestasis, Intrahepatic; Female; Humans; I | 2001 |
[Two pediatric cases of malignant hyperthermia caused by sevoflurane].
Topics: Anesthetics, Inhalation; Child; Dantrolene; Female; Humans; Infant; Male; Malignant Hyperthermia; Me | 2001 |
Possible association of malignant hyperthermia with sevoflurane anesthesia.
Topics: Adult; Anesthesia; Anesthetics; Child; Ethers; Female; Humans; Male; Malignant Hyperthermia; Methyl | 1992 |
Malignant hyperthermia during sevoflurane anesthesia.
Topics: Anesthetics; Ethers; Humans; Malignant Hyperthermia; Methyl Ethers; Sevoflurane | 1992 |
Malignant hyperthermia during sevoflurane anesthesia in a child with central core disease.
Topics: Anesthesia, Inhalation; Blepharoptosis; Child, Preschool; Ethers; Female; Humans; Malignant Hyperthe | 1991 |